Estee Lauder Lives On

Recs

0

Estee Lauder's (NYSE: EL) 97-year-old founder may have passed away earlier this week, but her namesake company's quarterly results today imply its brand's lasting appeal. If makeup can be considered a safe haven in tough economic times, look out when times get better.

Fiscal third-quarter numbers came in better than expected due to increased sales volume towards the end of the quarter, Estee Lauder said in its conference call (transcript courtesy of CCBN StreetEvents). Profit increased by 26% to $98.3 million, or $0.42 per share. Net sales increased 15%, and if you take out the foreign currency benefits, they increased 10%. Both the U.S. retail recovery and a pickup in European travel were cited as reasons for the pretty picture.

The company had a tough act to beat this time around, when you consider last year's third-quarter earnings, which rose 79%. It expects full-year earnings of $1.59 to $1.62 per share, with a 13% increase in sales.

Estee Lauder encompasses more than just the self-titled line of cosmetics. It's also the name behind popular brands like MAC, Clinique, Prescriptives, and Aveda. Rivals include the likes of L'Oreal (which, despite its drugstore image, also provides Lancome and Kiehl's), Procter & Gamble (NYSE: PG), and Revlon (NYSE: REV). There's also the living-room approach to marketing cosmetics, embodied by Mary Kay and Avon (NYSE: AVP).

However, many of these competitors appeal to a different demographic than most of Estee Lauder's brands, which are featured in luxury retailers like Neiman-Marcus (NYSE: NMGA) or Nordstrom (NYSE: JWN). And one thing you'll notice about the recent retail revival is that interest in high-end goods has been at the forefront of the recovery.

As a result of Estee Lauder's passing, the company will receive a $0.06-per-share earnings benefit related to royalties it won't have to pay to her. In addition, it may buy back preferred shares from her estate, resulting in savings of another $0.06 in interest expenses.

The current climate's one where a more confident consumer puts her best face forward, and Estee Lauder's brands seem to be showing strong traction with shoppers. Now that the stock's trading at 27 times forward earnings, with revenues growing at levels reminiscent of strength back in 2000, Estee Lauder may be getting ready to turn investors' heads once again.

Looking for stocks that are more than just a pretty face? Consider subscribing to Motley Fool Stock Advisor.

Alyce Lomax does not own shares of any companies mentioned. She happens to be a loyal Prescriptives customer.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 507338, ~/Articles/ArticleHandler.aspx, 11/10/2009 12:46:42 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:01 PM
AVP $33.84 Up +0.72 +2.17%
Avon Products, Inc… CAPS Rating: ***
EL $47.14 Up +0.39 +0.83%
The Estee Lauder C… CAPS Rating: *
JWN $35.16 Up +1.23 +3.63%
Nordstrom, Inc. CAPS Rating: **
PG $61.85 Up +0.81 +1.33%
The Procter & Gamb… CAPS Rating: *****
REV $14.79 Up +4.01 +37.20%
Revlon, Inc. CAPS Rating: *

Community: Investing Wiki

Term Of The Hour

Borrowing: Borrowing is the process of getting the loan of an asset from another entity usually in return for interest.

Want to learn more or edit this definition?
Click here to read more!